M

Medicinova
D

MNOV

2.21000
USD
0.04
(1.84%)
Market Closed
Volume
0
EPS
-0
Div Yield
-
P/E
-11
Market Cap
108,392,204
Related Instruments
    A
    ARWR
    -0.020
    (-0.10%)
    19.450 USD
    B
    BNTC
    -0.842
    (-6.85%)
    11.448 USD
    C
    CRVS
    -0.08000
    (-1.57%)
    5.01000 USD
    N
    NVAX
    0.05000
    (0.58%)
    8.72000 USD
    T
    TRVN
    -2.02000
    (-44.99%)
    2.47000 USD
    V
    VKTX
    0.780
    (1.88%)
    42.270 USD
    More
News

Title: Medicinova

Sector: Healthcare
Industry: Biotechnology
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.